|
Name of digestive system tumor | Intervention measures of the control group | Outcome indicators | The dominant varieties of traditional Chinese medicine injection obtained by cluster analysis |
|
Gastric cancer | FOLFOX chemotherapy regimen | Total clinical effective rate, quality of life, and adverse reactions | Astragalus polysaccharide injection, Kangai injection, sodium pincer, and vitamin B injection |
Gastric cancer | XELOX chemotherapy regimen | Total clinical effective rate, quality of life, and adverse reactions | Brucea javanica oil emulsion injection, compound Sophora flavescens injection, Lentinan injection |
Esophageal cancer | Radiotherapy | Clinical total effective rate, quality of life, adverse reactions, survival rate | Compound Sophora flavescens injection, Shenqi Fuzheng injection, compound Sophora flavescens injection, Cinobufagin injection, Kangai injection |
Esophageal cancer | Chemotherapy | Total clinical effective rate, quality of life, and adverse reactions | Compound Sophora flavescens injection |
Liver cancer | TACE | Clinical total effective rate, quality of life, adverse reactions, survival rate | Brucea javanica oil emulsion injection, cinobufagin injection, Kanglaite injection, astragalus polysaccharide injection, Shenmai injection |
Colon cancer | FOLFOX chemotherapy regimen | Total clinical efficiency and quality of life | Xiaoaiping injection |
Pancreatic cancer | Chemotherapy | Total clinical effective rate, quality of life, and adverse reactions | Javanica oil emulsion injection, Kanglaite injection, Aidi injection |
|